139 related articles for article (PubMed ID: 33238076)
1. Withdrawn: Predicting the lethal toxicity of psychoactive substances.
King LA
Drug Test Anal; 2022 Jun; 14(6):1170. PubMed ID: 33238076
[No Abstract] [Full Text] [Related]
2. Comparison of acute lethal toxicity of commonly abused psychoactive substances.
Gable RS
Addiction; 2004 Jun; 99(6):686-96. PubMed ID: 15139867
[TBL] [Abstract][Full Text] [Related]
3. Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.
Liakoni E; Dolder PC; Rentsch KM; Liechti ME
BMC Pharmacol Toxicol; 2016 May; 17(1):25. PubMed ID: 27228985
[TBL] [Abstract][Full Text] [Related]
4. Occurrence, ecotoxicity and ecological risks of psychoactive substances in surface waters.
Ding L; Zhang CM
Sci Total Environ; 2024 May; 926():171788. PubMed ID: 38499097
[TBL] [Abstract][Full Text] [Related]
5. Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act.
Craft S; Dunn M; Vidler D; Officer J; Blagbrough IS; Pudney CR; Henderson G; Abouzeid A; Dargan PI; Eddleston M; Cooper J; Hill SL; Roper C; Freeman TP; Thomas SHL
Addiction; 2022 Nov; 117(11):2899-2906. PubMed ID: 35665553
[TBL] [Abstract][Full Text] [Related]
6. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies.
Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432
[TBL] [Abstract][Full Text] [Related]
7. Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis.
Al-Banaa I; Hawkins L; Hill SL; Lupton DJ; Jackson G; Sandilands EA; Bradberry SM; Thompson JP; Rushton S; Thomas SHL
Int J Drug Policy; 2020 Mar; 77():102672. PubMed ID: 32032867
[TBL] [Abstract][Full Text] [Related]
8. Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act.
Webb NE; Wood DM; Greene SL; Hunter LJ; Archer JRH; Dines AM; Dargan PI
Clin Toxicol (Phila); 2019 Jan; 57(1):36-41. PubMed ID: 30067112
[TBL] [Abstract][Full Text] [Related]
9. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA).
Weber C; Smith JL; Soderstrom J; Burrows S; McCutcheon D; Oosthuizen F; Fatovich DM;
Clin Toxicol (Phila); 2023 Jul; 61(7):500-508. PubMed ID: 37449677
[TBL] [Abstract][Full Text] [Related]
10. Environmental occurrence and ecological risks of psychoactive substances.
Jin H; Yang D; Wu P; Zhao M
Environ Int; 2022 Jan; 158():106970. PubMed ID: 34753034
[TBL] [Abstract][Full Text] [Related]
11. Temporal associations between use of psychoactive substances and somatic symptoms in the daily lives of people with fibromyalgia.
Kuzu D; Valentine TR; Kratz AL
Pain Med; 2023 Oct; 24(10):1176-1182. PubMed ID: 37243707
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Acute Toxicity Associated with New Psychoactive Substances.
Hill SL; Dargan PI
Handb Exp Pharmacol; 2018; 252():475-494. PubMed ID: 29896654
[TBL] [Abstract][Full Text] [Related]
13. Understanding the risks associated with the use of new psychoactive substances (NPS): high variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products.
Zamengo L; Frison G; Bettin C; Sciarrone R
Toxicol Lett; 2014 Aug; 229(1):220-8. PubMed ID: 24910986
[TBL] [Abstract][Full Text] [Related]
14. Use of psychoactive substances among university students from 2019 to 2020: A systematic review.
Sampaio GR; Lima GS; de Souza SB; Soares DM
Brain Behav Immun Health; 2024 Feb; 35():100724. PubMed ID: 38292320
[TBL] [Abstract][Full Text] [Related]
15. Overview of analytical methods for determining novel psychoactive substances, drugs and their metabolites in biological samples.
Musiał J; Czarny J; Gadzała-Kopciuch R
Crit Rev Toxicol; 2022 Mar; 52(3):239-258. PubMed ID: 36040410
[TBL] [Abstract][Full Text] [Related]
16. Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill.
Reuter P; Pardo B
Addiction; 2017 Jan; 112(1):25-31. PubMed ID: 27220685
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and risk assessment of psychoactive substances in tap water from China.
Wang Z; Gao S; Dai Q; Zhao M; Yang F
Environ Pollut; 2020 Jun; 261():114163. PubMed ID: 32078882
[TBL] [Abstract][Full Text] [Related]
18. An index of fatal toxicity for new psychoactive substances.
King LA; Corkery JM
J Psychopharmacol; 2018 Jul; 32(7):793-801. PubMed ID: 29482434
[TBL] [Abstract][Full Text] [Related]
19. An Expanding World of Novel Psychoactive Substances: Opioids.
Zawilska JB
Front Psychiatry; 2017; 8():110. PubMed ID: 28713291
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.
Helander A; Beck O; Hägerkvist R; Hultén P
Scand J Clin Lab Invest; 2013 Aug; 73(5):400-6. PubMed ID: 23692208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
